Data Availability
No datasets were generated or analysed during the current study.
References
Salminen P, Kow L, Aminian A, et al. IFSO Consensus on definitions and clinical practice guidelines for obesity management—an international Delphi study. Obes Surg. 2024;34(1):30–42.
Phelps NH, Singleton RK, Zhou B, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027–50.
Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2020–2021: current trends for bariatric and metabolic procedures. Obes Surg. 2024;34(4):1075–85.
Murphy R, Plank LD, Clarke MG, et al. Effect of banded Roux-en-Y gastric bypass versus sleeve gastrectomy on diabetes remission at 5 years among patients with obesity and type 2 diabetes: a blinded randomized clinical trial. Diabetes Care. 2022;45:1503–11.
Helmiö M, Victorzon M, Ovaska J, et al. SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surg Endosc. 2012;26:2521–6.
Peterli R, Wolnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319:255–65.
Schauer PRP, Kashyap SRS, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.
Climent E, Benaiges D, Pedro-Botet J, et al. Laparoscopic Roux-en-Y gastric bypass vs. laparoscopic sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of lipid effects at one year postsurgery. Minerva Endocrinol. 2018;43:87–100.
Climent E, Goday A, Pedro-Botet J, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for 5-year hypertension remission in obese patients: a systematic review and meta-analysis. J Hypertens. 2020;38(2):185–95.
Benaiges D, Goday A, Casajoana A, et al. Short-term effects of gastric bypass versus sleeve gastrectomy on high LDL cholesterol: the BASALTO randomized clinical trial. Cardiovasc Diabetol. 2024;23:1–14.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
Collaboration S working group and EC risk, Hageman S, Pennells L, Ojeda F, et al. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42:2439–54.
Busetto L, Dicker D, Frühbeck G, et al. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024;30:2395–9.
Peterli R, Hurme S, Bueter M. Standardized assessment of metabolic bariatric surgery outcomes: secondary analysis of 2 randomized clinical trials. JAMA Surg. 2024;159:306–14.
Author information
Authors and Affiliations
Contributions
D.B. and A.C. wrote the main manuscript text, and J.P.B. provided guidance based on his extensive experience and expertise in the scientific field. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Benaiges, D., Pedro-Botet, J. & Casajoana, A. Time to Put LDL Cholesterol on the Roadmap in Bariatric Surgery Guidelines. OBES SURG (2024). https://doi.org/10.1007/s11695-024-07591-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11695-024-07591-w